Gu‐Wei Ji

机构：Hebei Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Second Hospital of Hebei Medical University, National Center of Neurology and Psychiatry, Chinese Academy of Medical Sciences Dermatology Hospital, Taiyuan Iron and Steel Group (China), Changchun University of Chinese Medicine, Jiangsu Cancer Hospital, Jiangsu Province Hospital, Henan Medical University, Nanjing Medical University · ORCID：0000-0003-1736-062X

发表论文 55 篇 · 总被引 1633 次 · h-index 16

代表论文

• Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial (2022 · Journal for ImmunoTherapy of Cancer · 被引 218)
• Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma (2023 · Journal for ImmunoTherapy of Cancer · 被引 59)
• Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection (2021 · Journal of Hepatocellular Carcinoma · 被引 48)
• Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma (2022 · BMC Cancer · 被引 47)
• Integrating Machine Learning and Tumor Immune Signature to Predict Oncologic Outcomes in Resected Biliary Tract Cancer (2020 · Annals of Surgical Oncology · 被引 17)
• Rim Enhancement and Peripancreatic Fat Stranding in Preoperative MDCT as Predictors for Occult Metastasis in PDAC Patients (2023 · Academic Radiology · 被引 16)